ReviewMolecular medicine reports2026
Role of the PI3K/AKT signaling pathway in regulating gene expression in rheumatoid arthritis (Review).
Review in Molecular medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by synovial inflammation and joint destruction. As the disease progresses, joint deformity, loss of joint function and disability may occur, thereby seriously affecting the quality of life of patients, as well as their physical and mental health. The PI3K/AKT signaling pathway serves a critical role in regulating inflammatory responses, cell survival and gene expression in RA. The present review aimed to summarize how PI3K/AKT modulates the expression of key genes involved in RA pathogenesis, including cytokines and non‑coding RNAs. In addition, the crosstalk between PI3K/AKT and other signaling pathways, as well as the potential therapeutic strategies currently available for RA, are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.